Literature DB >> 24948657

Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects.

Roel P Gazendam1, John L van Hamme1, Anton T J Tool1, Michel van Houdt1, Paul J J H Verkuijlen1, Martin Herbst2, Johannes G Liese2, Frank L van de Veerdonk3, Dirk Roos1, Timo K van den Berg1, Taco W Kuijpers4.   

Abstract

Invasive fungal infections, accompanied by high rates of mortality, represent an increasing problem in medicine. Neutrophils are the major effector immune cells in fungal killing. Based on studies with neutrophils from patients with defined genetic defects, we provide evidence that human neutrophils use 2 distinct and independent phagolysosomal mechanisms to kill Candida albicans. The first mechanism for the killing of unopsonized C albicans was found to be dependent on complement receptor 3 (CR3) and the signaling proteins phosphatidylinositol-3-kinase and caspase recruitment domain-containing protein 9 (CARD9), but was independent of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. The second mechanism for the killing of opsonized C albicans was strictly dependent on Fcγ receptors, protein kinase C (PKC), and reactive oxygen species production by the NADPH oxidase system. Each of the 2 pathways of Candida killing required Syk tyrosine kinase activity, but dectin-1 was dispensable for both of them. These data provide an explanation for the variable clinical presentation of fungal infection in patients suffering from different immune defects, including dectin-1 deficiency, CARD9 deficiency, or chronic granulomatous disease.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24948657     DOI: 10.1182/blood-2014-01-551473

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  71 in total

Review 1.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

2.  Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation.

Authors:  Zhifang Cao; Kara L Conway; Robert J Heath; Jason S Rush; Elizaveta S Leshchiner; Zaida G Ramirez-Ortiz; Natalia B Nedelsky; Hailiang Huang; Aylwin Ng; Agnès Gardet; Shih-Chin Cheng; Alykhan F Shamji; John D Rioux; Cisca Wijmenga; Mihai G Netea; Terry K Means; Mark J Daly; Ramnik J Xavier
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

Review 3.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

Review 4.  Antifungal innate immunity: recognition and inflammatory networks.

Authors:  Katharina L Becker; Daniela C Ifrim; Jessica Quintin; Mihai G Netea; Frank L van de Veerdonk
Journal:  Semin Immunopathol       Date:  2014-12-20       Impact factor: 9.623

5.  Protection of Candida parapsilosis from neutrophil killing through internalization by human endothelial cells.

Authors:  Kyle A Glass; Sarah J Longley; Joseph M Bliss; Sunil K Shaw
Journal:  Virulence       Date:  2015       Impact factor: 5.882

6.  Human invasive mycoses: immunogenetics on the rise.

Authors:  Michail S Lionakis; Steven M Holland
Journal:  J Infect Dis       Date:  2014-07-23       Impact factor: 5.226

7.  Secretory aspartyl proteinases induce neutrophil chemotaxis in vivo.

Authors:  Arielle M Bryan; Maurizio Del Poeta
Journal:  Virulence       Date:  2016-06-30       Impact factor: 5.882

8.  CBLB ubiquitin ligase: a major regulator of antifungal immunity.

Authors:  Frank L van de Veerdonk; Mihai G Netea
Journal:  Nat Med       Date:  2016-08-04       Impact factor: 53.440

9.  Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients.

Authors:  M Carmen Herrero-Sánchez; Eduardo B Angomás; Cristina de Ramón; Juan J Tellería; Luis A Corchete; Sara Alonso; M Del Carmen Ramos; María J Peñarrubia; Saioa Márquez; Nieves Fernández; Luis J García Frade; Mariano Sánchez Crespo
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

Review 10.  Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.